5F-PB-22: Difference between revisions

Line 86:

*'''United Kingdom''' - 5F-PB-22 is a class B drug under the third-generation synthetic cannabinoids generic definition, which came into effect on the 14th December 2016 and is illegal to possess, produce, supply, or import. <ref>The Misuse of Drugs Act 1971 (Amendment) Order 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/uksi/2016/1109/made</ref>

*'''United States''' - In January 2014, 5F-PB-22 was designated as a Schedule I controlled substance in the United States.<ref>http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0110_10.htm</ref>

*'''Germany''' - On December 13, 2014 5F-PB-22 was added to the ~~controlled substance act ("~~BtMG"), making it illegal to ~~produce~~, sell or ~~possess~~.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref>

*'''Germany''' - On December 13, 2014 5F-PB-22 was added to Anlage II of the BtMG, making it illegal to manufacture, import, possess, sell, or transfer it without a license.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref><ref>http://www.gesetze-im-internet.de/btmg_1981/anlage_ii.html</ref>

*'''Latvia''' - 5F-PB-22 is a Schedule I drug.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (Indola-3-karbonskābes esteri) | http://likumi.lv/doc.php?id=121086</ref>

*'''China''' - As of October 2015 5F-PB-22 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

@@ Line 86: / Line 86: @@
 *'''United Kingdom''' - 5F-PB-22 is a class B drug under the third-generation synthetic cannabinoids generic definition, which came into effect on the 14th December 2016 and is illegal to possess, produce, supply, or import. <ref>The Misuse of Drugs Act 1971 (Amendment) Order 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/uksi/2016/1109/made</ref>
 *'''United States''' - In January 2014, 5F-PB-22 was designated as a Schedule I controlled substance in the United States.<ref>http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0110_10.htm</ref>
-*'''Germany''' - On December 13, 2014 5F-PB-22 was added to the controlled substance act ("BtMG"), making it illegal to produce, sell or possess.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref>
+*'''Germany''' - On December 13, 2014 5F-PB-22 was added to Anlage II of the BtMG, making it illegal to manufacture, import, possess, sell, or transfer it without a license.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref><ref>http://www.gesetze-im-internet.de/btmg_1981/anlage_ii.html</ref>
 *'''Latvia''' - 5F-PB-22 is a Schedule I drug.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (Indola-3-karbonskābes esteri) | http://likumi.lv/doc.php?id=121086</ref>
 *'''China''' - As of October 2015 5F-PB-22 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>